MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal CancerShelize Khakoo, David Cunningham, Paul Carter et al.|Clinical Cancer Research|2019Cited by 138
Prediction of<sup>177</sup>Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN StudyMagdalena Mileva, Ioannis Karfis, Konstantinos Stathopoulos et al.|Journal of Nuclear Medicine|2023Cited by 52
Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature reviewVasiliki Michalarea, Maria Antonietta Bali, Elisa Fontana et al.|Current Problems in Cancer|2019Cited by 16
DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastasesMihaela Rata, Matthew Orton, Khurum Khan et al.|Cancer Imaging|2021Cited by 11
Hepatic schwannoma: CT and histologic featuresSimona Picchia, Maria Antonietta Bali, Monica Terlizzo|Current Problems in Cancer|2018Cited by 5